Hormel Foods shows steady sales growth and sharpens focus on profitable protein categories amid sector struggles.

Hormel Foods has demonstrated resilience in the challenging packaged foods sector by achieving five consecutive quarters of organic net sales growth. The company’s recent sale of its whole-bird turkey business allows it to concentrate on higher-margin, value-added protein products, which improves earnings stability and reduces volatility. Management remains cautiously optimistic, maintaining full-year guidance for modest organic sales and operating income growth, alongside a projected EPS range of $1.43 to $1.51. With a 5.7% dividend yield and reasonable valuation, Hormel is considered a cautious Buy, appearing closer to a turnaround than many peers in the industry.